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Summary 
Chemical mapping methods probe RNA structure by revealing and leveraging correlations of a 
nucleotide’s structural accessibility or flexibility with its reactivity to various chemical probes.  
Pioneering work by Lucks and colleagues has expanded this method to probe hundreds of 
molecules at once on an Illumina sequencing platform, obviating the use of slab gels or capillary 
electrophoresis on one molecule at a time. Here, we describe optimizations to this method from 
our lab, resulting in the MAP-seq protocol (Multiplexed Accessibility Probing read out through 
sequencing), version 1.0. The protocol permits the quantitative probing of thousands of RNAs at 
once, by several chemical modification reagents, on the time scale of a day using a table-top 
Illumina machine. This method and a software package MAPseeker 
(http://simtk.org/home/map_seeker) address several potential sources of bias, by eliminating 
PCR steps, improving ligation efficiencies of ssDNA adapters, and avoiding problematic 
heuristics in prior algorithms. We hope that the step-by-step description of MAP-seq 1.0 will 
help other RNA mapping laboratories to transition from electrophoretic to next-generation 
sequencing methods and to further reduce the turnaround time and any remaining biases of the 
protocol.  
 
Introduction 
RNAs play an active role in all kingdoms of life (1, 2), with known functions including catalysis 
(2, 3), gene regulation (4), genome maintenance (5), and protein synthesis (1).  The functions of 
RNA molecules appear to be critically dependent on their structures or, in the case of gene 
translation, their lack of structure. Comparative sequence analysis, x-ray crystallography, and 
NMR (6, 7) remain the gold standards for inferring functional secondary structures and tertiary 
interactions in RNA molecules. However, all three of these tools require significant investigator 
insight and effort and are not generally tractable for all RNAs.  When these methods have not 
been applicable, chemical probing has been a valuable tool, particularly to falsify or support 
preexisting structural models (8-10). Enhancing the information content of chemical probing  to 
permit de novo structure determination, to leverage novel chemical probes, and to accelerate  
RNA design are ongoing areas of research (11-15). Most chemical probes tend to react with 
nucleotides that are solvent-exposed, flexible, or otherwise uninvolved in canonical or non-
canonical base pairing (16-22). These reactivities are often read out via a reverse transcriptase 
reaction that extends a DNA primer complementary to the modified RNA (16-22). The reverse 
transcriptase stops at the site of a modification, leaving a complementary DNA (cDNA) whose 
length marks the modified nucleotide.  To identify the sites of the reactive nucleotides, the pool 
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of cDNAs is typically analyzed through length separation by gel or capillary electrophoresis 
(CE), using radiolabeled or fluorophore-labeled primers, respectively.  
 
With magnetic bead purifications and 96-well plates, mapping several dozen RNAs with a set of 
different chemical reagents is now feasible on the time scale of a day (see Chapter on the 
Mutate-and-Map method, in this volume). However, some applications, such as characterizing 
RNAs discovered by high-throughput biological screens or created by computational design (13), 
require probing 1000s of RNAs. Enzymatic mapping, which gives sparse reads, can be carried 
out on such large pools—or, indeed, at a genome-wide scale (23-25)—through next-generation-
sequencing, but these data do not carry the information content of single-nucleotide-resolution 
chemical probes. An experimental protocol and bioinformatics pipeline developed by Lucks and 
colleagues has pioneered the use of 2´-OH acylating reagents and Illumina next-generation 
sequencing (NGS) to enable highly parallel chemical mapping of several RNAs (26, 27), but the 
method has not yet been applied to RNAs of many distinct sequences or with alternative 
chemical probes (26). Furthermore, in our hands, this method leads to mapping profiles that do 
not agree within error with measurements from replicate mapping experiments based on capillary 
electrophoresis. The differences are at least partially due to the sequence-dependence of ligation 
and amplification steps that have been used to prepare libraries for Illumina sequencing 
(unpublished data).  
 
To increase the rate at which a large number of RNAs may be probed and to reduce bias, we 
have further advanced this protocol into a MAP-seq (Multiplexed Accessibility Probing) method 
(Figure 1).  Multiple chemical reactions, such as DMS alkylation (12), carbodiimide 
modification of bases (12, 28) and acylation of the 2´-hydroxyl (21, 22) can be carried out in 
parallel (Figure 2). Addition of an Illumina adapter sequence to reverse transcribed DNA is 
carried out under conditions that give near-quantitative single stranded DNA ligation (29, 30). 
Unique sequence identifiers at the 3´ ends of each the RNA are sequestered into hairpins (Figure 
1, Table 1) to help prevent interference with the fold of the RNA segment of interest. Solution 
PCR steps, which can introduce significant length and sequence bias, are eliminated. Last, we 
noticed that current NGS sequence analysis packages (31-33) either became unusably slow 
and/or inaccurate in assigning reads at the 3´ ends of sequences and across highly similar 
sequences (e.g., single mutants in mutate-and-map experiments). We have therefore developed a 
new automated tool, called MAPseeker, which quantifies the reactivities of the nucleotides of 
each RNA under each condition. 
 
Comparisons of this NGS approach and prior CE methods are shown for different chemical 
modifiers in Figure 2. The data from the two techniques agree within the estimated error of each 
method, as can be seen in direct overlays for two RNAs (Figure 3). These data suggest that 
MAP-seq biases have been reduced to the point that the NGS-based data are as trustworthy as 
CE data.  
 
The MAP-seq protocol is rapidly evolving, with active developments to enhance multiplexing 
through “index” reads in Illumina machines, to probe oligonucleotide pools and sub-pools 
derived from massively parallel synthesis technologies, and to tackle RNAs with lengths of 
kilobases.  Continuing improvements in single-stranded DNA ligation, through new enzymes 
and solution conditions (34, 35), may further reduce any residual bias at this step. This chapter 
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gives a snapshot of our stable “version 1.0” lab protocol that runs on the table-top MiSeq 
platform for RNA pools with lengths up to 200 nucleotides. 
 
Materials 
General Materials 
The protocol given below assumes that four chemical probes will be tested on the pool of RNAs: 
no modification (addition of water or DMSO), DMS, CMCT, and 1M7. We carry out some steps 
of this procedure within wells of a 96-well plate, which enables use of magnetic separators and 
multichannel pipetters and can reduce the experimentalist’s effort. Alternatively, the entire 
protocol can also be carried out in RNAse-free non-stick Eppendorf tubes. We use a capillary 
electrophoresis (CE) sequencer and fluorescent primers to check the yield and length distribution 
at two steps prior to Illumina sequencing. Use of fluorescent DNA is particularly convenient for 
rapidly piloting improvements to the protocol and for directly comparing  CE data to Illumina 
data. As an alternative, steps to monitor the lengths of DNA fragments can also be carried out 
without fluorescent primers on, e.g., Agilent Bioanalyzer systems (26). 
1. One 96-well V-bottom plate (E&K scientific). 
2. Three or more plastic seal films (EdgeBio Systems). 
3. 24-post and 96-post magnetic stand (VP Scientific). 
4. Plenty of RNase-free sterile water. 
5. 10 mL 70% ethanol, freshly prepared. 
6. At least 120 μL 40% polyethylene glycol 8000. 
7. ROX-Formamide mix: Mix 1 µL of ROX 350 ladder (Applied Biosystems) in 350 µL of 
Hi-Di formamide. This volume is enough for five 4-sample reactions and can be stored 
frozen at –20 °C. 
8. Two 96-well format dry incubators (Hybex, SciGene), set to 55 °C and 90 °C before 
starting the chemical mapping part of this protocol. If these types of incubators are not 
available, a water bath or thermocycler may be substituted. 
9. Access to an ABI 3100 sequencer or similar equipment for capillary electrophoresis. 
 
Chemical Modification of RNA 
It is assumed that the investigator has already obtained the RNA molecules of interest, either by 
chemical synthesis, in vitro transcription, or extraction from cells or viruses. The protocol below 
has been tested most thoroughly on pools of RNAs that have identical primer binding sites (PBS) 
at their 3´ ends. In addition, it is critical that the last segment of each sequence (RID in Figure 1), 
immediately 5´ to the reverse transcription binding site, be unique in the pool (26, 27). These 
nucleotides (8 in our example cases below; see Table 1) are used later to identify the RNA with 
which each NGS read is associated. In our examples, these 8 nucleotides are arbitrary octamers, 
but we also included additional complementary nucleotides to sequester the RID into a hairpin 
capped by a UUCG tetraloop (Table 1), which reduces the potential for this added sequence 
interfering with the RNA fold. Aside from these PBS and RID segments, there are few other 
constraints. We have carried out MAP-seq on RNA pools with between one and 4000 distinct 
sequences in a single experiment.  
 
Different chemical modification reagents probe different nucleotides and different aspects of the 
RNA structure.  Each reagent may need its own quench.  We list the recipes for most common 
modification reagents and their quenches at concentrations and reaction times appropriate for 
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RNAs under 100 nucleotides in length.  Longer RNAs should use lower concentrations and/or 
shorter reaction times.  When deviating from these conditions or using alternative reagents, the 
RNA molecules should be modified with single-hit frequency, which may depend on reagent 
concentration, reaction time, and temperature. The protocol given below assumes that four 
chemical probes will be tested on the pool of RNAs: no modification (addition of water or 
DMSO), DMS, CMCT, and 1M7.  Every 4-sample reaction will require the following: 
1. Each reaction should use 2.5 to 5.0 pmol of total RNA (5 μL of 0.5–1.0 μM RNA). 
2. 10.0 µL of 0.5 M Na-HEPES, pH 8.0 (from a sterile stock filtered with a 0.2 µm filter). 
Other pH stocks can be used, but note that carbodiimide and 2´-hydroxyl modification 
reactions, as well as other modifers, are sensitive to pH.   
3. 20 µL of 50 mM MgCl2 if the RNA requires magnesium for proper folding.  If not, 20 µL 
5 M NaCl can be used to give 1 M NaCl conditions; or other folding buffer.   
4. 280 μL Agencort AMPure XP (Beckman Coulter) for RNA purification.  (See Note 1 and 
Note 2).  
5. DMS mix for dimethyl sulfate mapping, which attacks exposed Watson-Crick faces of 
adenines and cytosines in RNA and DNA: Mix 1.0 µL fresh dimethyl sulfate (Sigma) 
into 9.0 µL 100% ethanol, then add 90.0 µL of sterile water. The quench for this reaction 
is 2-mercaptoethanol (Sigma). Each DMS reaction needs 5 μL DMS mix. 
6. CMCT mix for carbodiimide mapping using 1-cyclohexyl-(2-
morpholinoethyl)carbodiimide metho-p-toluene sulfonate (CMCT), which attacks 
exposed Watson-Crick faces of guanines and uracils in RNA: Mix 42 mg/ml of CMCT in 
H2O. The solid stock for reagent is usually kept at -20 ° C. Before mixing into water, 
incubate it at room temperature for 15 minutes, immediately prior to experiment. The 
quench for this reaction is 0.4 M Na-MES, pH 6.0. Each CMCT reaction needs 5 μL 
CMCT mix. 
7. 1M7 mix for 2´-hydroxyl acylation  mapping using 1-methyl-7-nitroisatoic anhydride 
(1M7), a fast-acting reagent which attacks dynamic nucleotides by modifying the 2´ 
hydroxyl of an RNA: Mix 10 mg of 1M7 into 1 mL anhydrous DMSO. The quench for 
this reaction is 2-mercaptoethanol (Sigma). Each 1M7 reaction needs 5 μL 1M7 mix. An 
alternative reagent for 2´-hydroxyl acylation is N-methylisatoic anhydride (NMIA). 
 
Reverse Transcription 
1. 4 μL 5X First Strand buffer (Invitrogen)  
2. 1 μL 0.1 M DTT (Invitrogen)  
3. 1.6 μL dNTPs mixture (10 mM each nucleotide) per sample plate 
4. 1.0 μL 40% PEG 8000 
5. 0.4 μL 200 U/μL SuperScript III (Invitrogen) reverse transcriptase  
6. 0.5 μL each of at least four 1 μM reverse transcription primers per sample.  These 
primers contain the Illumina adapter for bridge amplification at the 5´ ends, followed by 
the Illumina sequencing primer binding sequence, followed by a primer identifier 
sequence (PID; see Figure 1), and finished with a region to bind the conserved 3´ ends of 
the RNAs. The PID region is 12 nucleotides long and must be sequence-balanced as part 
of a set of four primers (See Note 3 and Table 1). The different PIDs can be used to 
distinguish between the same RNA modified by different reagents or subject to different 
modification reaction conditions.  The primers should be purified by polyacrylamide gel 
electrophoresis (PAGE) or HPLC. 
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7. 0.25 μL of 1 μM of at least one of the reverse transcription primers with a 5´ fluorescein 
(FAM) modification.   
8. Streptavidin-coated magnetic beads that have bound double-biotinylated oligos 
complementary to Illumina’s Oligo C sequence (Oligo C´ beads). These beads are 
assembled using DynaBeads (Invitrogen), using the manufacturer’s instructions for 
coupling to oligonucleotides under RNAse-free conditions. The oligonucleotide sequence 
ordered from Integrated DNA Technologies is in Table 1. 
9. 40 μL 0.4 M NaOH  
10. Acid quench mix, prepared by mixing 1 volume of 5 M NaCl, 1 volume of 2 M HCl, and 
1.5 volumes of 3 M sodium acetate (pH 5.2). This stock can be kept at room temperature 
for at least two months.  Of this mix, 40 μL are needed per 4-sample reaction. 
 
Ligation of Second Illumina Adapter 
Every 4-sample reaction requires: 
1. 2.5 μL 10 μM Read 2 PBS/Amplification 2 (Fig. 1, Table 1). This contains standard 
sequences used for bridge PCR amplification and 2nd read sequencing on Illumina 
platforms.  
2. 2 μL CircLigase ssDNA Ligase (Epicentre, Illumina) 
3. 2 μL CircLigase ssDNA Ligase buffer (Epicentre, Illumina, supplied with CircLigase) 
4. 1 μL 1 mM ATP (supplied with CircLigase) 
5. 1 μL 50 mM MnCl2 (supplied with CircLigase) 
6. 2 μL 40% polyethylene glycol 8000 
7. 1 μL fluorescent oligo loading control mix: 1 nM fluorescein-labeled 20-nucleotide DNA 
oligomer and 1 nM fluorescein-labeled 40-nucleotide DNA oligomer (See Note 4). 
 
Final Preparation for Sequencing 
For every 4-sample reaction, you will need 
1. 0.5 μL 10 nM PhiX genomic DNA (20 nM of single strands), prepared for sequencing 
(Illumina, see Note 9).  
2. 2 μL 2.0 N NaOH (Illumina, or other supplier) 
3. 10.0 μL EB buffer (Qiagen) 
 
Methods 
 
All steps are at room temperature unless specified.   
 
Chemical Modification 
1. Prepare modification buffer at 2x concentration. For each 20 μL reaction, mix 2 μL 0.5 M 
Na-HEPES, pH 8.0, 4 μL appropriate salt solution (e.g., either 50 mM MgCl2 or 5 M 
NaCl, as above), and 4 μL RNase-free H2O. For four reactions, prepare enough premix 
for five reactions (e.g., 10 μL 0.5 M Na-HEPES, pH 8.0; 20 μL of 50 mM MgCl2; and 20 
μL RNase-free H2O). 
2. Add 5 μL of each RNA solution to as many samples in the 96-well plates as you have 
reagents and reaction conditions.  Add 10 μL of modification buffer to each well.  Seal 
the plate with sealer tape.  Let the RNAs fold at room temperature for 20 minutes, or, if 
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necessary, place into a thermocycler, and take the plate through the necessary 
temperature steps to ensure proper folding of the RNA or RNAs in question. 
3. While the RNA is folding, prepare fresh stocks of modification reagents as above.  
Always make sure that one of the modification conditions is just H2O or just anhydrous 
DMSO, as a control reading for background reverse transcriptase stops. Array the various 
modification reagents in the auxiliary plate so that they may be easily added to the main 
reaction plate. 
4. Add 5 μL of the modification reagent to each corresponding well of the main reaction 
plate. For four modification conditions [(A) no modification, (B) DMS, (C) CMCT, and 
(D) 1M7], use 5 μL of each stock reagents freshly prepared as above. The total volume in 
each of four reactions is now 20 μL.  
5. Seal the plate and let incubate.  For RNAs under 100 nucleotides with the modification 
reagents listed above, 30 minutes is appropriate.  For longer RNAs, less time may be 
necessary so as to achieve single-hit kinetics.  Alternative reagents may require their own 
modifications to this protocol (See Note 5). 
6. While the RNAs are incubating with the modification reagents, array the quenches in 
corresponding locations in the auxiliary plate (or in a new auxiliary plate) so that they 
may be easily added to the main reaction plate.  After the appropriate incubation time, 
add 20 μL of the corresponding quench to each well. The volume of each sample is now 
40 μL.   
7. Prepare the bead purification mix: for each reaction well: mix 70 μL AMPure XP beads 
with 30 μL 40% polyethylene glycol 8000.  Pipette up and down at least 10 times to mix.  
Add 100 μL bead purification mix (2.5x volumes) to each reaction.  Again pipette up and 
down at least 10 times to mix.  Wait 10 minutes for the beads to bind the RNA (See Note 
2). 
8. Set the plate on a 24-post magnetic stand and wait 5 minutes for the beads to collect near 
magnets. 
9. Pipette off the supernatant and discard.   
10. Rinse the beads with 100 μL 70% ethanol.  Shake briefly with the plate on the stand(s).  
Wait 30 seconds. Remove the 70% ethanol supernatant 
11. Repeat step 10.  This time, take extra care to remove the last traces of the 70% ethanol 
supernatant with a P10 pipette (See Note 6). 
12. Let the samples dry for 10 minutes while remaining on the magnetic stand.  Remove any 
final visible droplets of 70% ethanol with a P10 pipette. 
13. Resuspend the beads in each well in 2.5 μL RNase-free H2O.Take the plate off the 
magnetic stand(s).  Let stand for 5 minutes to ensure release of RNAs. 
14. Place the plate back on the magnetic stand(s).  Wait 1-2 minutes for the beads to collect.  
Transfer the supernatant in each well, which now contain the released, modified RNA, to 
a new plate. 
 
Reverse Transcription 
1. Prepare fresh primer stocks (See Note 4), 1 μM each.  Primers should be used in sets of 4, 
which will be referred to as A-D within one set—primer A for the first reaction in a set of 
four, primer B for the second, etc.  All primers in a set need to be used, due to sequence 
balancing requirements of the Illumina platform (See Note 3, Table 1 for example 
sequences). For at least one primer (primer A in this example), however, instead of using 
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pure unlabeled primer, prepare a mixture from equal parts 1 μM unlabeled primer A and 
1 μM fluorescently-labeled primer A to use as the primer for the reaction in a group of 
four. This fluorescent tracer will allow for a rapid quality check by standard capillary 
sequencing prior to running on the Illumina sequencer. It is also fine to use pure 
fluorescently labeled primer A, or to label all primers in use. The fluorophore labeled 
cDNA does not interfere with the Illumina sequencing protocol (it is washed away during 
the bridge PCR on the Illumina flow cell). 
2. Add 0.5 μL 1.0 μM of the corresponding primer to appropriate well of the plate 
containing the modified RNAs. 
3. Prepare the SuperScript III reverse transcription mix: for each reaction, mix 1 µL of 5X 
First Strand buffer, 0.25 µL of 0.1 M DTT, 0.4 µL of 10 mM dNTPs, 0.25 μL 40% PEG 
8000, and 0.1 µL Superscript III reverse transcriptase.   
4. Add 2.0 µL of the SuperScript III reverse transcription mix: for each reaction mix to each 
well.  Mix well by pipetting up and down at least 10 times.  The total volume of the 
reactions is 5 µL. 
5. Seal the sample plate well.  Put it in an incubator set to 55 ºC for 30 minutes.  For longer 
RNAs, longer incubation times may be used to help complete reverse transcription. 
6. After 30 min, hydrolyze the leftover RNA by adding 5 µL of 0.4 M NaOH to each well. 
Incubate the plate at 90 ºC for 3 minutes. 
7. Add 5 µL of the acid quench mix (see recipe in Reverse Transcription materials section) 
to each well. Let the plate cool on ice for 5 minutes. 
8. Add 4 µL of the Oligo C´ beads (see recipe in Reverse Transcription materials section) to 
each well.  Mix thoroughly by pipetting up and down at least 10 times.  Incubate at room 
temperature 10 minutes to ensure cDNA binding to the beads. 
9. Place the plate on a magnetic stand and wait 1-5 minutes for the beads to collect.   
10. Pipette off the supernatant and discard.   
11. Rinse the beads with 100 μL 70% ethanol.  Shake briefly by hand with the plate on the 
stand(s).  Wait 30 seconds. Remove the 70% ethanol supernatant. 
12. Repeat step 10.  This time, take extra care to remove the last traces of the 70% ethanol 
supernatant with a P10 pipette (See Note 6). 
13. Let the samples dry for 5 to 10 minutes while remaining on the magnetic stand.  Remove 
any final visible droplets of 70% ethanol with a P10 pipette, and let dry further for 5 
minutes. 
14. Take the plate off the magnetic stand(s).  Resuspend the beads in each well in 2.5 μL 
RNase-free H2O. 
15. Take 0.5 μL from every sample reverse transcribed with the primer A/fluorescent primer 
A mixture and transfer to a new plate.  Add 10 μL of the ROX-formamide mixture to 
each of these representative samples and mix.  Wait 5 minutes to ensure release of 
cDNA. 
16. Place this new plate on a magnetic stand.  Wait 1-5 minutes for the beads to aggregate.  
Transfer the supernatant to an optical plate used by an ABI capillary electrophoresis 
sequencer.  These samples can be loaded on an ABI sequencer to ensure reverse 
transcription worked properly before proceeding to the ligation step (see below); 
alternatively they can be loaded at the same time as the ligated samples to save effort.   
17. The remaining samples (still with beads) may be pooled for convenience before 
proceeding.  Ensure the beads are still well-suspended in water by pipetting up and down. 
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In the example case with one pool of RNAs modified under 4 conditions, the total 
volume of the combined samples will be 8 μL. 
 
Ligation of the Second Illumina Adapter 
1. Set one incubator or water bath to 68 ºC.  Set a second at 80 ºC.   
2. Prepare the CircLigase ligation mix: for every 4-sample reaction, combine 2.5 μL of 10 
μM DNA oligo of second Illumina adapter sequence, phosphorylated at both the 5´ and 3´ 
ends; 2.0 μL CircLigase ssDNA Ligase buffer; 1.0 μL 1 mM ATP; 1.0 μL 50 mM MnCl2; 
2.0 μL 40% polyethylene glycol 1500; 1.5 μL of RNAse-free H2O; and 2.0 μL 
CircLigase ssDNA Ligase (See Note 8). The adapter can also be blocked at its 3´ end 
with a spacer modification instead of a phosphate. 
3. Add 12 μL of CircLigase ligation mix to the combined cDNA sample pool of each 4-
sample reaction.  Incubate at 68 ºC for 2 hours, then 80 ºC for 10 minutes to inactivate the 
ligase. This incubation can be carried out in a thermocycler.  The oligo C´ beads do not 
appear to affect the efficiency of the ligation (unpublished data).  
4. Add 5 μL 5 M NaCl and mix thoroughly by pipetting up and down.  This will ensure 
proper resuspension of the beads, and raise the salt concentration to ensure proper 
hybridization of cDNA to oligo C´ beads. 
5. Remove 10 μL to a well of a new 96-well plate.  This sample fraction will be another 
quality check prior to sequencing.  The remaining 15 μL of the pool will be used for 
sequencing.   
6. Wait 5 minutes to ensure rebinding of the cDNAs to the beads.  Place the plate on 
magnetic stand(s).  Wait 1-5 minutes for the beads to collect. 
7. Pipette off the supernatant and discard.   
8. Rinse the beads with 100 μL 70% ethanol.  Shake briefly with the plate on the stand(s).  
Wait 30 seconds. Remove the 70% ethanol supernatant. 
9. Repeat step 8.  This time, take extra care to remove the last traces of the 70% ethanol 
supernatant with a P10 pipette (See Note 6). 
10. Let the samples dry for 5 minutes while remaining on the magnetic stand.  Remove any 
final visible droplets of 70% ethanol with a P10 pipette. 
11. For the sequencing samples, take the plate off the magnetic stand.  Resuspend the beads 
of a pool in 8 μL of RNase-free H2O per 4 samples in the pool.  Leave these pools 
separate until after quantifying the amount of cDNA in each pool. 
12. For the quality check samples, take the plate off the magnetic stand.  Resuspend each 
pool of beads in 10 μL of ROX-Formamide mix.  Place the plate back on a magnetic 
stand. Wait 1-5 minutes for the beads to collect.  Transfer the supernatant to an optical 
plate appropriate for an ABI capillary electrophoresis sequencer.  Add 1 μL fluorescent 
oligo loading control mix (See Note 4) and mix well by pipetting up and down.  Run 
these samples on the ABI capillary electrophoresis sequencer. 
 
Quality Check of Ligation and Quantification of Final Sample for Sequencing 
The following steps are based on using the suite of HiTRACE scripts for MATLAB 
(https://simtk.org/home/hitrace) (36).  The general strategy for this step is to integrate the area of 
the peaks corresponding to the two fluorescent oligos in the loading control mix, which each 
should correspond to approximately 1 fmol of sample, average them, and then compare their 
areas to the combined area under the peaks corresponding to the ligated samples.  Below are 
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commands to be executed within MATLAB after having downloaded the HiTRACE scripts and 
added them to the MATLAB path. MATLAB and other computer syntax, functions, and variable 
names are written in an alternate font. 
1. Verify that the ligation proceeded correctly.  Execute the following command: 
d = quick_look({‘foldername_with_ABI_data’}, lowerbound, 
upperbound) 
foldername_with_ABI_data corresponds to the path of the folder containing the 
data from the quality check immediately after reverse transcription, and the quality check 
after ligation.  The numbers lowerbound and upperbound depend on the length of 
the RNA(s) in question.  In the resulting view of the capillary traces, ensure that bands 
are visible for the reverse transcribed product, typically with a strongest band for the fully 
extended product (see Figure 4).  Another band may be visible for unextended primer, 
although in many experiments we do not see this peak (Figure 4A), as our primer (Table 
1) tends to be efficiently extended. In the second, ligated sample, check that this pattern 
of peaks has shifted to longer lengths (later elution times) after ligation (Figure 4B). In 
principle this ligation should be quantitative but this is not always the case, and the 
fraction ligated should be estimated (see Note 7). 
2. Subtract the baseline from the data contained in d and store it in a matrix called d_bsub: 
d_bsub = baseline_subtract_v2(d); 
3. Plot the baseline-subtracted data: 
figure(5) % This creates a new figure window within MATLAB 
in which to plot the data. 
plot(d_bsub(:,2)) 
Here, it is assumed that the second column of d_bsub corresponds to the ligated sample. 
Use this plot to identify the bounds on the time axis for the shorter oligo peak, the longer 
oligo peak, and the fully-ligated cDNA region.  Record these values as 
shorter_lower, shorter_upper, longer_lower, longer_upper, 
cdna_lower, and cdna_upper. 
4. Calculate the area of the peaks in the cDNA region by summation: 
cdna_area = sum(d_sub(cdna_lower:cdna_upper,2)) 
5. Calculate the area of the peak for the shorter oligo: 
shorter = sum(d_bsub(shorter_lower:shorter_upper,2)) 
6. Calculate the area of the peak for the longer oligo: 
longer = sum(d_bsub(longer_lower:longer_upper,2)) 
7. Calculate the number of fmols in the 15 µL of sample that can be loaded on the Illumina 
platform (See Note 9) 
fmols = 24 * cdna_area / (shorter + longer) 
 
Final Preparation for Sequencing on a MiSeq 
1. These instructions, especially the amounts of cDNA loaded, are specific for running on a 
MiSeq using Illumina’s version 2 kits.  If an alternative platform is used, this protocol 
will need to be appropriately adjusted. Place a MiSeq version 2 reagent kit in a pool of 
water as deep as the fill line on the kit to thaw.  Place the HT1 buffer vial in the kit on the 
bench top to thaw, then keep on ice. 
2. The target is to load 30 fmol of cDNA onto the MiSeq plus 5 fmol of the PhiX genome as 
a positive control.  Thirty divided by the number of pools of samples is the number of 
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femtomoles taken from each pool.  Given the quantifications of the number of 
femtomoles in each pool calculated above, calculate the volume of sample needed to be 
taken from each pool and contributed to the final pool that will be used for sequencing. 
3. If the yield of cDNA from a pool is high, such that the volume of sample to be taken from 
the pool is less than 0.5 μL in order for it to provide its amount of cDNA, then first take a 
small aliquot of beads and add EB buffer to dilute down such that the target number of 
femtomoles will be in a 0.5 to 4.5 μL volume. 
4. If the yield of cDNA from a pool is low, such that the volume of the library needed to get 
the desired amount of cDNA is in excess of 4.5 μL, put the pool in a well on a 96-well 
plate, and place the plate on a magnetic stand.  Wait 1-2 minutes for the beads to collect. 
Discard the supernatant.  Remove the plate from the stand.  Resuspend the beads in the 
desired volume of EB buffer.  Our experiments have show that the beads do not release a 
significant amount of cDNA into the supernatant when resuspended in water at the end of 
the ligation stage.  Instead, NaOH is necessary to denature the DNA and release it from 
the beads (see steps 7 and 8 below). 
5. If the volume of the final combined pool of the cDNA library is less than 4.5 μL, add EB 
buffer such that the final volume equals 4.5 μL. 
6. Take 1.0 μL of 10 nM PhiX control sample and put it in a well of a 96-well plate.  Add 
1.0 μL of EB buffer.  Mix by pipetting up and down.  Take 0.5 μL of this solution and 
add it to the final pool of cDNA (on beads). 
7. Take 2.0 μL of 2.0 M NaOH and put it in a well of a 96-well plate.  Add 18 μL of 
deionized water and mix by pipetting up and down.  Add 5 μL of this solution to the final 
pool of cDNA beads plus PhiX.  Mix thoroughly by pipetting up and down.  The final 
volume will be 10 μL. 
8. Let the solution stand for 5 minutes for the DNA to denature.  Place the plate on a 
magnetic stand.  Wait 1-5 minutes for the beads to collect.  Transfer the supernatant to a 
1.5 mL tube. 
9. Add 990 μL of chilled HT1 buffer to the 1.5 mL tube.  Mix thoroughly by pipetting up 
and down.  Transfer 375 μL of this solution to a new 1.5 mL tube.  Add 225 μL of 
additional HT1 buffer and again mix thoroughly by pipetting up and down. (See Note 10 
and Note 11). 
10. Proceed following Illumina’s protocol for loading this final 600 μL solution in the 
reagent cartridge and loading the cartridge and flow-cell on the MiSeq. Use paired-end 
sequencing so as to be able read out both the position of the reverse transcription stop and 
the identity of the RNA in the cluster.  The RNA can be of arbitrary length as each 
sequence is identified by its 3´ RID (Fig. 1) during the first read on Illumina’s 50-cycle 
kits. The first read must be long enough to read through the primer’s PID, the 20-
nucleotide RNA binding site (RBS), and then through enough nucleotides of the RID 
region to distinguish the sequence from any other in the pool. Our RNAs typically have 
RID regions of 8-15 nucleotides. Such an RNA pool would require a first read length of 
47 nucleotides.  The second read must be long enough to uniquely identify the position of 
the reverse transcription stop compared to any other position in the RNA.  We typically 
use 20-30 nucleotides, although this may vary depending on the sequence of the RNA.  If 
RNAs in the pool contain long repetitive sequences, the second read will need to be 
longer so as to extend into the non-repetitive regions (The 50 cycle kit can, when used in 
the manner of this protocol, be used to read 76 nucleotides, summed over the first and 
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second read.) Illumina’s kits include read allotments for indexing above and beyond the 
stated read lengths that we do not use – we use the barcoding and identification schemes 
described here instead.   
 
MAPseeker analysis 
1. The MAPseeker package is freely available for download at: 
https://simtk.org/home/map_seeker. Follow the instructions in the README to install on 
a Mac or other Unix-based machine. 
2. Prepare two text files in FASTA format, with a label for each sequence on one line 
preceded by a “>” character, and the sequence following on the next line.  The first 
FASTA file (“RNA_sequences.fasta”) should contain the full-length sequences 
of every RNA in the run.  The second (“primers.fasta”) should contain the full 
sequence of every reverse transcription primer used in the run. 
3. The MAPseeker executable takes input in the following format: 
$ MAPseeker -1 read1.fastq  -2 read2.fastq  -l 
RNA_sequences.fasta  -p primers.fasta  -n 8 
The files read1.fastq and read2.fastq are the FASTQ format sequence files 
from the MiSeq.  The two .fasta files are those prepared in step 1.  The flag “-n” 
specifies the length of the RID region of the RNA (8, in this example).   
4. As output, MAPseeker gives summary statistics: the numbers of sequences found in the 
FASTQ files, the number in which the RNA binding site was found, the number that 
contained a primer ID that was specified in primers.fasta, and the number of 
sequences from read 1 and read 2 that matched an RNA sequence specified in 
RNA_sequences.fasta.  It also gives text files named stats_ID1.txt through 
stats_IDN.txt, where N is the number of primers listed in primers.fasta 
(stats_ID1.txt corresponds to the first primer in primers.fasta, etc.).  The text files contain 
tab-separated matrices of numbers.  Each row corresponds to an RNA as they were listed 
in the RNA_sequences.fasta file.  Each column corresponds to the site where 
reverse transcription stopped, beginning at 0 (full extension of the RT primer back to the 
RNA 5´ end) and ending at the 3´ end.  Stops in the RID region as specified by “-n” 
above will all be zero, as they cannot be attributed conclusively to any one RNA.  The 
values correspond to the number of clusters from the sequencing run of the particular 
RNA that stopped at that position.   
5. The data in these text files are tab-delimited, so they are amenable to analysis with a most 
visualization or plotting programs, or to be further processed with custom analysis 
scripts. MAPseeker includes scripts in MATLAB (located in the src/matlab/ subdirectory) 
for quick data analysis and visualization. This protocol will describe the use of these 
MATLAB scripts.  For ease of use, add the map-seeker/src/matlab/ directory to your 
MATLAB path, and set the present working directory to the directory containing the 
stats_IDN.txt files as well as the two input FASTA files. Run from within MATLAB: 
[D, RNA_info, primer_info, D_correct, D_correct_err ] = 
quick_look_MAPseeker('RNA_sequences.fasta','primers.fasta',
'./') 
This gives several windows. One is a histogram of counts per primer, and counts per 
RNA (figure window 1 within MATLAB; see Fig. 5A). Further windows give 
visualization of the counts (with estimated errors) for the four most highly represented 
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RNAs and 'reactivities', corrected for reverse transcriptase attenuation as given by the 
following equation (26, 37): 
 
R(site i) = F(site i) / [F(site 0) + F(site 1) +  ...  + F(site i) ]  (eq. 1) 
 
If the ligation of the fully extended product [F(site 0)] was not quantitative, this factor 
can be taken into account in the quick_look_MAPseeker function (Note 7). The 1D 
profiles of the RNAs with the most reads are shown (figure windows 2 and 3 within 
MATLAB; see Fig. 5B), as well as 2D representation of the entire data set (Figure 
windows 4 and 5 within MATLAB; see Fig. 5C). The 2D representations permit visual 
confirmation that the ID region of the RNA is folded into a hairpin; the 5´ strand of the 
stem should be protected to chemical modification, and the loop should be reactive. (The 
chemical reactivity of the 3´strand of the hairpin is not observable as it is used to identify 
the RNA; stops in this region result in reads that cannot be uniquely aligned to the library 
of RNA sequences.)  All figure windows are also automatically saved to disk as 
encapsulated PostScript (EPS) files. 
6. The output matrix D contains the raw counts of stop positions for each RNA. The 
matrices D_correct and D_correct_err have the reactivities and their estimated 
errors. They are cells with one matrix for each primer. RNA_info has information on the 
sequences and descriptions of the RNA library. The errors are based on Poisson statistics 
(note: sites with zero counts are assumed to have errors of ±1). To perform background 
subtraction of the data for primer 2 (a DMS condition in this example), using the control 
data for primer 1 (a mock treatment condition in this example) execute: 
[D_sub, D_sub_err] = subtract_data( D_correct{2}, 
D_correct{1},D_correct_err{2}, D_correct_err{1} ); 
Repeat this for any other pairs of modification reagent condition and its corresponding 
mock treatment condition to generate similar matrices.  
7. These data may be output into an RDAT file for convenient sharing and analysis.  The 
necessary RDATkit scripts come installed with HiTRACE, or a separate installation can 
be downloaded at https://simtk.org/home/rdatkit. Then type: 
filename = 'Example_output.rdat'; 
name = 'My Library'; 
annotations = {'experimentType:StandardState','chemical:Na-
HEPES:50mM(pH8.0)','chemical:MgCl:10mM','temperature:24C','
processing:overmodificationCorrectionRigorous','processing:
backgroundSubtraction','modifier:DMS}; 
comments = {'Test of Miseq data output.', 'Used MAPseeker 
v1.0'}; 
output_MAPseeker_data_to_rdat_file( filename, name, D_sub, 
D_sub_err, annotations, comments, RNA_info ); 
The RDAT file is formatted with the specifications available at 
http://rmdb.stanford.edu/repository/specs/.  Structure analysis scripts, including helix-by-
helix confidence estimation, are available on-line at: 
http://rmdb.stanford.edu/structureserver/. RDAT files can also be read and further 
analyzed via Python or MATLAB with the RDATkit scripts 
(https://simtk.org/home/rdatkit).     
Massively parallel chemical mapping 
 13 
 
Notes 
1. Alternative purification.  If the number of wells used ends up being small (enough to fit 
in a microcentrafuge) or if the length of the RNA is less than approximately 50 
nucleotides (under the cutoff for AMPure XP purification), ethanol precipitation (0.1 
volumes of 3 M sodium-acetate pH 5.2, then 3 volumes of cold ethanol; incubation in dry 
ice for 20 minutes; spin >15000g in a microcentrifuge for 20 minutes) can be used 
instead of AMPure XP purification.  However, AMPure XP beads are more convenient 
for purifying a large number of samples. 
2. AMPure XP beads should not be mixed with the modification reagents for longer than the 
times prescribed in this protocol.  The reagents and quenches may damage them and ruin 
the purification.  If the beads turn from brown to green, then the purification has likely 
failed. 
3. Illumina’s MiSeq platform requires that the first 12 reads made by the sequencer are 
“sequence-balanced,” namely, that there are approximately an equal number of A’s, C’s, 
G’s, and T’s read across all the clusters.  This is not much of a problem for genomic 
DNA, but the cDNA libraries described here all begin with the same 20-nucleotide 
primer binding site, which would ruin the sequence balancing.  So, immediately upstream 
of the primer region is a 12-nucleotide sequence-balancing region. We also use this 
region as a unique primer identifier (PID) for which chemical modification reaction a 
given cluster came from. Primers must be made and used in sets of four; within each set 
of four, one primer must have an A at the first position, another must have a C at the first 
position, etc.  Our sequences (Table 1) were designed to minimize secondary structure 
with the primer region (as assessed with NUPACK) (38) while maintaining sequence 
balance and disallowing 4 or more Gs in a row in any primer.  
4. The loading control sequences we use are in Table 1. We had these sequences on hand 
for other applications.  Other sequences should work just as well, as long as their lengths 
are less than the reverse transcription primers used above, so that their signals appear at 
locations distinct from the library in the capillary electrophoretic trace. Note that at low 1 
nM concentration, these oligos may stick to the sides of conventional 1.5 mL tubes, 
lowering the accuracy of the control over time; use of non-stick tubes and storage of 
stocks at concentrations greater than 100 nM are recommended. 
5. Only one site of modification can be identified by reverse transcription, so it is important 
to choose reaction conditions that modify each RNA once or not at all.  Longer RNAs 
have more sites that can be modified, so it is important to lower reaction times and/or 
concentrations of reagents. 
6. Ethanol is strong inhibitor of reverse transcription and ligation.  It needs to be completely 
removed by pipetting and evaporation, with no remaining liquid visible and with the 
beads appearing dried out. 
7. The factor of 24 comes from the fact that the number of femtomoles of sample being read 
by the sequencer is 1/8 of the amount of primer used in the transcription, and the 
remaining sample is 1.5 times larger than the aliquot used in the quantification.  The final 
factor of two comes from averaging the areas of the smaller and larger oligo peaks, by 
which the area under the library peaks is divided. 
8. Using CircLigase (i.e., TS2126 thermostable RNA ligase), we typically observe that the 
ligation of the adapter to reverse transcription products is near quantitative (>80%) in a 
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sequence-independent manner, within the detection limits of capillary electrophoresis. 
The one exception is that the fully extended product is ligated with poorer efficiency 
(~50%; Figure 4A and 4B); it is not yet clear if this is due to a sequence bias (our 
transcripts begin with GG, leaving CC at the 3´ ends of these cDNA primer extension 
products) or to addition of some ligation-blocking modification by SuperScript III reverse 
transcriptase on cDNA that has completely extended to the end of an RNA. In any case, if 
the ligation efficiency of the full product is known, it can be specified at the time of data 
analysis and correction as a fourth argument in quick_look_MAPseeker. The default 
correction factor is 2.0; changing this number will affect the overall scale of the final 
reactivities and, less sensitively, the correction for attenuation which reweights the 
balance of short and long reverse transcription products [equation (1)].   
9. Accurate quantification of the cDNA library is critical for acquiring high-quality 
sequencing data.  Loading too much sample will ruin the results due to too many 
overlapping clusters of DNA that cannot be distinguished from one another by the 
sequencer, and loading too little may not yield enough clusters for the Illumina platform 
to find the flow cell during initial auto-focus stages.  Also note that double-stranded 
DNA, such as the PhiX genomic DNA we recommend to be co-loaded with the single-
stranded cDNA library, produces twice as many clusters per mole as single-stranded 
cDNA. 
10. While it is possible to design a protocol that could conceivably discard less material than 
this one, the volumes involved for the early steps may be so small, depending on the yield 
after ligation, that it would typically be necessary to dilute down some of the pools of 
beads after ligation, and then end up discarding the leftover anyway.   
11. The 625 μL of solution left over after this step should be discarded, unless it is going to 
be used in a parallel MiSeq sequencing run on the same day. Our experience is that the 
solution is not useable for additional runs even if stored overnight at 4 ºC.  
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Table 1.  Sequences used in this protocol, all shown from 5´ to 3´. Color coding corresponds 
to regions highlighted in Fig. 1. Abbreviations for modifications are those used by Integrated 
DNA Technologies: /5phos/, 5´-phosphate; /3phos/, 3´-phosphate; /iBioT/, internal biotinylated 
T; /3Bio/, 3´ biotin; /5-6FAM/, 5´-6-fluorescein. 
 
 
Example 
DNA 
Transcription 
Templates 
TTCTAATACGACTCACTATAGGAAAATATTAATTCTTTAATAAAAACTATCCGTTCGCGGATAGAAAAGAAACAACAACAACAAC  
TTCTAATACGACTCACTATAGGAAACAAAAAAAAAAACGGCGATACGGATCGAGGCGAATTCGCCACATAGAAATATGGCGGAAA
AAACAGACGGTTCGCCGTCTGAAAAGAAACAACAACAACAAC  
TTCTAATACGACTCACTATAGGAAACAAAAAAAAAAACGGCGATACGGATCGAGGCGAATTCGCCACATAGAAATATGGCGGAAA
AAAATGCACGTTCGCGTGCATAAAAGAAACAACAACAACAAC  
TTCTAATACGACTCACTATAGGAAACAAAAAAAAAGGGCAGATCGAAAGATCAGTATAAGGGTACAGTACGAGGGTACAGCAAAA
AAAACGCGACTTCGGTCGCGTAAAAGAAACAACAACAACAAC  
TTCTAATACGACTCACTATAGGAAACAAAAAAAAAGGGCAGATCGAAAGATCAGTATAAGGGTACAGTACGAGGGTACAGCAAAA
AAAGGTTAGCTTCGGCTAACCAAAAGAAACAACAACAACAAC  
TTCTAATACGACTCACTATAGGAAACAAAAAAAAACTGCACGAAAAAATTCGAGCTGAAAACAGCAGGTTAAAAAGCCAGCCAAA
AAACATAGCGTTCGCGCTATGAAAAGAAACAACAACAACAAC  
Example 
RNAs 
GGAAAAUAUUAAUUCUUUAAUAAAAACUAUCCGUUCGCGGAUAGAAAAGAAACAACAACAACAAC  
GGAAACAAAAAAAAAAACGGCGAUACGGAUCGAGGCGAAUUCGCCACAUAGAAAUAUGGCGGAAAAAACAGACGGUUCGCCGUCU
GAAAAGAAACAACAACAACAAC  
GGAAACAAAAAAAAAAACGGCGAUACGGAUCGAGGCGAAUUCGCCACAUAGAAAUAUGGCGGAAAAAAAUGCACGUUCGCGUGCA
UAAAAGAAACAACAACAACAAC  
GGAAACAAAAAAAAAGGGCAGAUCGAAAGAUCAGUAUAAGGGUACAGUACGAGGGUACAGCAAAAAAAACGCGACUUCGGUCGCG
UAAAAGAAACAACAACAACAAC  
GGAAACAAAAAAAAAGGGCAGAUCGAAAGAUCAGUAUAAGGGUACAGUACGAGGGUACAGCAAAAAAAGGUUAGCUUCGGCUAAC
CAAAAGAAACAACAACAACAAC  
GGAAACAAAAAAAAACUGCACGAAAAAAUUCGAGCUGAAAACAGCAGGUUAAAAAGCCAGCCAAAAAACAUAGCGUUCGCGCUAU
GAAAAGAAACAACAACAACAAC  
Reverse 
Transcription 
Primers A-D 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTACCAGGCGCTGGGTTGTTGTTGTTGTT
TCTTT  
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTGAGGCCTTGGCCGTTGTTGTTGTTGTT
TCTTT  
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTTAAAATATAGTTGTTGTTGTTGTT
TCTTT  
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTGACTTGCACATGTTGTTGTTGTTGTT
TCTTT  
Illumina 
Adapter for 
cDNA 
ligation 
/5phos/AGATCGGAAGAGCGGTTCAGCAGGAATGCCGAGACCGATCTCGTATGCCGTCTTCTGCTTG/3phos/ 
Oligo C´ 
[double 
biotinylated] 
TGTGTAGATCTCGGTGGTCGCCGTATCATTTTTTTTTTTT/iBiodT//3Bio/  
Loading 
Control 1 
/5-6FAM/AAAAAAAAAAAAAAAAAAAAGTTGTTGTTGTTGTTTCTTT 
Loading 
Control 2 
/5-6FAM/GTTGTTGTTGTTGTTTCTTT 
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Figure 1. Overview of the MAP-seq experimental protocol. Each RNA has a primer binding site 
at its 3´ end (PBS), preceded by an RNA ID (RID) unique to each sequence, which we usually 
sequester into a hairpin (Table 1). First, the RNA is subject to modification by a chosen chemical 
reagent. The site of modification is denoted with an asterisk. Second, the RNA is reverse 
transcribed using a primer that has at its 3´ end an RNA binding site (RBS) complementary to 
the primer binding site (PBS). The primer contains a sequence-balanced 12-nucleotide primer 
identification region (PID), and segments necessary for sequencing read 1 and bridge 
amplification in the Illumina flow cell. Third, the second Illumina adapter containing the read 2 
PBS, and the other DNA necessary for bridge amplification is ligated to the 3´ end of each 
cDNA with a single-stranded DNA ligase. Additional sequence segments within the Illumina 
adapters (gray) can be used for further multiplexing of experimental conditions, but are not used 
in the current protocol. 
*
* PIDRBS
* PIDRBS Amplification 1cDNA
PID RBSRead 1 PBSAmplification 1 cDNA
Read 1 PBS
Amplification 2Read 2 PBS
Amplification 2Read 2 PBS
1. Chemical Modification
Amplification 1Read 1 PBS
2. Reverse Transcription
3. Adapter Ligation
4. Illumina Sequencing-by-Synthesis [no amplification necessary]
5´- -3´
Oligo C´
RNA PBSRID
5´- -3´RNA PBSRID
5´- -3´RNA PBSRID
5´- -3´RNA PBSRID
5´-
3´-
-3´-
-3´ p-5´- -3´-p
-3´-p
-5´
-5´
Bead
PID RBSRead 1 PBSAmplification 1 cDNA5´-
-3´-Bead Oligo C´
DMS,CMCT, 1M7, or other modifiers
thermostable reverse transcriptase
thermostable single-stranded DNA ligase
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Figure 2. Comparison of capillary electrophoresis data (CE) and MAP-seq data on a double 
hairpin RNA Therm1, probed under control conditions (no modifier), with dimethyl sulfate 
(DMS), N-methylisatoic anhydride (NMIA), and 1-cyclohexyl(2-morpholinoethyl) carbodiimide 
metho-p-toluene sulfonate (CMCT). Raw data are shown: experimental capillary electrophoretic 
traces (left, arbitrary units; longer products on left) and number of reads (right). When 
quantitated and displayed on the predicted secondary structure (middle; red indicates reactivity 
of most reactive nucleotide), the modifiers indicate that the first of two predicted hairpins in the 
Therm1 construct is significantly melted in the tested conditions (24 °C; 1 M NaCl; 50 mM Na-
HEPES, pH 8.0), as compared to the second longer hairpin. 
no modification
Capillary electrophoresis
GGAA AAU AUUAAUUCUUUAAUA A AA ACUAUCC G UUCGCGGAUAG A −3’5’−
DMS
GGAA AAU AUUAAUUCUUUAAUA A AA ACUAUCC G UUCGCGGAUAG A −3’5’−
SHAPE
GGAA AAU AUUAAUUCUUUAAUA A AA ACUAUCC G UUCGCGGAUAG A −3’5’−
CMCT
GGAA AAU AUUAAUUCUUUAAUA A AA ACUAUCC G UUCGCGGAUAG A −3’5’−
GGA A A A U A U U A A U U C U U U A A U A A A A A C U A U C C G U U CG CGG A U A G A −3’5’−
MiSeq
no modification counts: 70310
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Figure 3. Quantitative agreement of MAP-seq data (black) with ‘gold standard’ capillary 
electrophoresis data (red) taken in replicate. (A) 2´-OH acylation data using the 1M7 (1-methyl-
7-nitroisatoic anhydride) modifier for an RNA from the EteRNA massively parallel design 
platform (from a player’s project “Neck Length 2-4”). (B) 1M7 data for the Therm1 hairpin (see 
also Figure 2). Error bars for the MAP-seq data were estimated from statistical error on the 
number of reads (smaller than the line width at most sequences), as carried out by MAPseeker 
analysis. Error bars for the CE data were estimated after HiTRACE quantitation (36) as the 
standard deviation across five measurements using 1M7 concentrations of 0.625, 1.25, 2.5, 5, 
and 10.0 mg/mL, and an additional two replicates in the 10 mg/mL condition. Two regions that 
show discrepancy between the CE and MAP-seq data beyond this error are highlighted with 
stars; both cases can be traced to band compression in the CE experiments (not shown), which 
introduces systematic uncertainty in band deconvolution near guanosine residues. 
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Figure 4. Quality check and quantitation of NGS library concentration through the use of a 
fluorescent ‘tracer’ primer and capillary electrophoresis. The sample shown corresponds to a 
four sample MAP-seq experiment (no modification, DMS, NMIA, CMCT) with a single RNA 
(Therm1; see Table 1), also shown in Figure 2. Note that the left-to-right orientation of bands is 
the reverse of the orders in Figures 2-3 and 5; signals corresponding to stops at more 
3´nucleotides are detected at earlier times in electrophoresis. (A) The data shown are for a 
fluorescein-labeled primer included in the reverse transcription reaction with the DMS sample; a 
fraction of this reaction was loaded on an ABI 3100 sequencer sensitive to fluorescein. (B) After 
the final Illumina adapter ligation step. The sample loaded here on the ABI 3100 sequencer was 
a fraction of the sample actually loaded on the Miseq Illumina platform. A clear shift to longer 
electrophoresis times (longer products; right-hand peaks) is apparent. Comparison of the 
integrated intensity of the ligated products to loading control peaks (1 fmol fluorescein-labeled 
controls; left-hand peaks) gives an estimate of the total ligated product. 
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